Loading...
BUY now for an event-driven upside skew. SEM is trading at $14.98, notably below the Executive Chairman’s non-binding $16.00–$16.20 take-private indication, creating a near-term re-rating/arb-style opportunity. Technically the stock is sitting just above support (14.83/14.66) with momentum no longer accelerating to the downside, which is a reasonable ‘buy-now’ level for an impatient buyer. Key payoff comes from any formalization/confirmation of the go-private process; if that progresses, the price has a clear path toward $16+.
Trend/Momentum: Slightly bearish-to-neutral. MACD histogram (-0.0585) is below zero (bearish) but negatively contracting, suggesting downside momentum is fading. RSI(6) at 42.2 is neutral-to-soft (not oversold). Levels: Price $14.98 is below pivot 15.113, so overhead resistance is near 15.11–15.39 (R1), then 15.57 (R2). Supports are close at 14.83 (S1) and 14.66 (S2). With price near support and momentum stabilizing, risk/reward favors a bounce attempt rather than chasing above 15.39. Pattern-based odds: Model indicates ~70% chance of a small dip next day (-0.56%), modest gain next week (+1.99%), and softer next month (-2.01%)—consistent with near-term chop unless a catalyst hits.
Intellectia Proprietary Trading Signals

Take-private indication: Executive Chairman/co-founder Robert Ortenzio’s non-binding $16.00–$16.20 cash indication creates a valuation anchor above the current price and can pull shares higher on any progression (formal offer, financing, special committee updates).
Earnings catalyst: Next earnings (QDEC
on 2026-02-19 after hours—any margin/profit stabilization could help fundamentals regain relevance if deal uncertainty clears.
Options positioning: Bullish-leaning open-interest skew (low OI put/call) aligns with upside expectations tied to corporate action.
Deal risk: The indication is non-binding; delay or failure to proceed could remove the $16+ anchor and pressure the stock.
Profitability trend: Q3 2025 showed sharp YoY declines in net income/EPS despite revenue growth, which weakens the fundamental backstop if corporate-action support fades.
Technical overhead supply: Resistance near 15.11–15.39 could cap near-term rallies without a confirming catalyst.
Latest quarter: 2025/Q3. Revenue grew to $1.363B (+7.22% YoY), but profitability weakened materially: Net income fell to $28.1M (-48.63% YoY) and EPS to $0.23 (-47.73% YoY). Gross margin improved to 8.29 (+4.41% YoY), suggesting some operational improvement, but it has not translated into bottom-line growth yet. Overall: top-line growth is positive, earnings trend is the main fundamental concern.
Recent trend: Ratings are effectively ‘deal-aware’ rather than purely fundamental.